Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Universal Health Services, Inc.’s stock clocked out at $223.27, up 0.64% from its previous closing price of $221.85. In other words, the price has increased by $0.64 from its previous closing price. On the day, 0.54 million shares were traded. UHS stock price reached its highest trading level at $224.0899 during the session, while it also had its lowest trading level at $219.67.
Ratios:
To gain a deeper understanding of UHS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 116.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.93. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.74.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on July 26, 2024, Upgraded its rating to Neutral and sets its target price to $219 from $162 previously.
On July 26, 2024, Barclays Upgraded its rating to Overweight which previously was Equal Weight but kept the price unchanged to $256.
Robert W. Baird Upgraded its Neutral to Outperform on June 26, 2024, whereas the target price for the stock was revised from $198 to $236.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 13 ’24 when SUSSMAN ELLIOT J MD MBA sold 1,722 shares for $218.08 per share. The transaction valued at 375,534 led to the insider holds 5,048 shares of the business.
Nimetz Warren J. sold 3,444 shares of UHS for $749,552 on Aug 12 ’24. The Director now owns 3,971 shares after completing the transaction at $217.64 per share. On Aug 13 ’24, another insider, ELLIOT SUSSMAN, who serves as the Director of the company, bought 1,722 shares for $218.08 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UHS now has a Market Capitalization of 14895056896 and an Enterprise Value of 19738179584. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.38, and their Forward P/E ratio for the next fiscal year is 12.77. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.00 while its Price-to-Book (P/B) ratio in mrq is 2.30. Its current Enterprise Value per Revenue stands at 1.314 whereas that against EBITDA is 9.806.
Stock Price History:
The Beta on a monthly basis for UHS is 1.27, which has changed by 0.7256534 over the last 52 weeks, in comparison to a change of 0.24841464 over the same period for the S&P500. Over the past 52 weeks, UHS has reached a high of $224.34, while it has fallen to a 52-week low of $119.90. The 50-Day Moving Average of the stock is 14.85%, while the 200-Day Moving Average is calculated to be 32.75%.
Shares Statistics:
It appears that UHS traded 734.44K shares on average per day over the past three months and 776820 shares per day over the past ten days. A total of 59.93M shares are outstanding, with a floating share count of 56.72M. Insiders hold about 15.25% of the company’s shares, while institutions hold 83.15% stake in the company. Shares short for UHS as of 1722384000 were 1674602 with a Short Ratio of 2.28, compared to 1719532800 on 1430742. Therefore, it implies a Short% of Shares Outstanding of 1674602 and a Short% of Float of 3.9100002000000003.
Dividends & Splits
With its trailing 12-month dividend rate of 0.8, UHS has a forward annual dividend rate of 0.80. Against a Trailing Annual Dividend Yield of 0.00360604The stock’s 5-year Average Dividend Yield is 0.51. The current Payout Ratio is 7.82% for UHS, which recently paid a dividend on 2024-06-03 with an ex-dividend date of 1725321600. Stock splits for the company last occurred on 2009-12-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
Investors are keenly observing as 12.0 analysts analyze and rate the current performance of Universal Health Services, Inc. (UHS) in the stock market.The consensus estimate for the next quarter is $4.23, with high estimates of $4.44 and low estimates of $3.98.
Analysts are recommending an EPS of between $16.14 and $15.69 for the fiscal current year, implying an average EPS of $15.94. EPS for the following year is $17.75, with 12.0 analysts recommending between $19.02 and $16.71.
Revenue Estimates
In the current quarter, 13 analysts expect revenue to total $3.9B. It ranges from a high estimate of $3.99B to a low estimate of $3.88B. As of the current estimate, Universal Health Services, Inc.’s year-ago sales were $3.54BFor the next quarter, 13 analysts are estimating revenue of $4.03B. There is a high estimate of $4.09B for the next quarter, whereas the lowest estimate is $3.98B.
A total of 16 analysts have provided revenue estimates for UHS’s current fiscal year. The highest revenue estimate was $15.76B, while the lowest revenue estimate was $15.61B, resulting in an average revenue estimate of $15.68B. In the same quarter a year ago, actual revenue was $14.28BBased on 15 analysts’ estimates, the company’s revenue will be $16.59B in the next fiscal year. The high estimate is $16.82B and the low estimate is $16.39B.
